Cyclin T1: a new oncogenic protein.

DE SIERVI A; DE LUCA P; MOIOLA C; COTIGNOLA J; ZALAZAR F; GARDNER K; VAZQUEZ E

Los cocos, Córdoba

Congreso; The First South American Spring Symposium in Signal Transduction and Molecular Medicine (SISTAM 2010).; 2010

Human Positive Transcription Elongation Factor b (PTEFb) is a protein kinase composed by CDK9 and Cyclin T that controls the elongation phase of RNA Pol II. This complex also affects the activation and differentiation program of lymphoid cells. In this study we found that several head and neck tumor cell lines overexpress PTEFb. We also established that Cyclin T1 is able to induce transformation in vitro, as we determined by foci and colony formation assays. Nu/nu mice s.c. injected with stable transfected Cyclin T1 cells (NIH 3T3 Cyclin T1) developed tumors faster than animals injected with control cells (NIH 3T3 b-gal).  In vitro, NIH 3T3 Cyclin T1 cells show increased proliferation and CDK4-Rb phosphorylation. Even more, silencing E2F1 expression (shRNA E2F1) in NIH 3T3 cells resulted in a dramatic inhibition of Cyclin T1-induced foci.   All these data demonstrate for the first time the Cyclin T1 oncogenic function and suggest a role for this protein in controlling cell cycle probably via Rb/E2F1 pathway.